ABBV
AbbVie Inc.
Stock
$263.29−2.99 (−1.12%)Close Sep 29, 2026
| Cash and short-term investments (Q2 2026) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $6.6B | +1.6% | −9.1% | −4.6% |
| Cash and short-term investments (Q2 2026) | $6.6B |
|---|---|
| YoY | +1.6% |
| 5-year CAGR | −9.1% |
| 10-year CAGR | −4.6% |
Cash and short-term investments
| Period | Cash | YoY |
|---|---|---|
| 2025 | $5.3B | −5.4% |
| 2024 | $5.6B | −56.7% |
| 2023 | $12.8B | +38.9% |
| 2022 | $9.2B | −6.1% |
| 2021 | $9.8B | +15.9% |
| 2020 | $8.5B | −78.8% |
| 2019 | $39.9B | +395.3% |
| 2018 | $8.1B | −17.7% |
| 2017 | $9.8B | +52.4% |
| 2016 | $6.4B | −23.6% |
| 2015 | $8.4B | +0.4% |
| 2014 | $8.4B | −15.4% |
| 2013 | $9.9B | +24.1% |
| 2012 | $8.0B | +29,440.7% |
| 2011 | $27M | — |